Juhua Zhou

Summary

Affiliation: National Institutes of Health
Country: USA

Publications

  1. pmc Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy
    Paul F Robbins
    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 173:7125-30. 2004
  2. pmc Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy
    Juhua Zhou
    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunother 28:53-62. 2005
  3. ncbi request reprint Breast cancer immunotherapy
    Juhua Zhou
    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Cell Mol Immunol 1:247-55. 2004
  4. pmc Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy
    Juhua Zhou
    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 175:7046-52. 2005
  5. pmc Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length
    Xinglei Shen
    Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunother 30:123-9. 2007
  6. pmc Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy
    Khoi Q Tran
    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 1201, USA
    J Immunother 31:742-51. 2008
  7. pmc Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma
    Juhua Zhou
    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 173:7622-9. 2004
  8. pmc Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene
    Cary Hsu
    Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 109:5168-77. 2007
  9. ncbi request reprint CD4+ T-cell response to mitochondrial cytochrome B in human melanoma
    Kui Shin Voo
    The Center for Cell and Gene Therapy and Department of Immunology, Baylor College of Medicine, Houston, Texas, USA
    Cancer Res 66:5919-26. 2006
  10. pmc Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasis
    Helen Y Wang
    The Center for Cell and Gene Therapy, Department of Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    J Exp Med 195:1397-406. 2002

Collaborators

Detail Information

Publications10

  1. pmc Cutting edge: persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy
    Paul F Robbins
    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 173:7125-30. 2004
    ....
  2. pmc Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy
    Juhua Zhou
    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunother 28:53-62. 2005
    ....
  3. ncbi request reprint Breast cancer immunotherapy
    Juhua Zhou
    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Cell Mol Immunol 1:247-55. 2004
    ..Clinical trials will approve that immunotherapy is an effective method to cure breast cancer disease in the near future...
  4. pmc Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy
    Juhua Zhou
    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 175:7046-52. 2005
    ....
  5. pmc Persistence of tumor infiltrating lymphocytes in adoptive immunotherapy correlates with telomere length
    Xinglei Shen
    Experimental Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunother 30:123-9. 2007
    ..These findings are relevant both to predicting effectiveness of adoptive immunotherapy and in deriving strategies for improving effectiveness by sustaining telomere length...
  6. pmc Minimally cultured tumor-infiltrating lymphocytes display optimal characteristics for adoptive cell therapy
    Khoi Q Tran
    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892 1201, USA
    J Immunother 31:742-51. 2008
    ....
  7. pmc Selective growth, in vitro and in vivo, of individual T cell clones from tumor-infiltrating lymphocytes obtained from patients with melanoma
    Juhua Zhou
    Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    J Immunol 173:7622-9. 2004
    ..A similar analysis may also be useful for monitoring autoimmune responses...
  8. pmc Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 gene
    Cary Hsu
    Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
    Blood 109:5168-77. 2007
    ..It does not appear that the retroviral vector integration sites played a role in the continuous growth of this cell clone, but this remains under investigation...
  9. ncbi request reprint CD4+ T-cell response to mitochondrial cytochrome B in human melanoma
    Kui Shin Voo
    The Center for Cell and Gene Therapy and Department of Immunology, Baylor College of Medicine, Houston, Texas, USA
    Cancer Res 66:5919-26. 2006
    ..These findings provide the first example of a mitochondrial immune target for CD4(+) T cells and therefore have implications for the immunosurveillance of mitochondrial aberrations in cancer patients...
  10. pmc Identification of a mutated fibronectin as a tumor antigen recognized by CD4+ T cells: its role in extracellular matrix formation and tumor metastasis
    Helen Y Wang
    The Center for Cell and Gene Therapy, Department of Immunology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA
    J Exp Med 195:1397-406. 2002
    ....